The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88.
He, Bing; Santamaria, Raul; Xu, Weifeng; Cols, Montserrat; Chen, Kang; Puga, Irene; Shan, Meimei; Xiong, Huabao; Bussel, James B; Chiu, April; Puel, Anne; Reichenbach, Jeanine; Marodi, László; Döffinger, Rainer; Vasconcelos, Julia; Issekutz, Andrew; Krause, Jens; Davies, Graham; Li, Xiaoxia; Grimbacher, Bodo; Plebani, Alessandro; Meffre, Eric; Picard, Capucine; Cunningham-Rundles, Charlotte; Casanova, Jean-Laurent; Cerutti, Andrea.
; 11(9): 836-45, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20676093
Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
B cell activating factor (BAFF) and BAFF receptors: fakes and facts.
The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.
Identify the key amino acid of BAFF binding with TACI.
Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.
Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
A proliferation-inducing ligand sustains the proliferation of human naïve (CD27â») B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen.